UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003333 |
|---|---|
| Receipt number | R000004043 |
| Scientific Title | Evaluation of circulating tumor cells in small cell lung cancer patients |
| Date of disclosure of the study information | 2010/03/13 |
| Last modified on | 2014/02/15 17:40:04 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of circulating tumor cells in small cell lung cancer patients
Acronym
Circulating tumor cells in small cell lung cancer
Scientific Title
Evaluation of circulating tumor cells in small cell lung cancer patients
Scientific Title:Acronym
Circulating tumor cells in small cell lung cancer
Region
| Japan |
Condition
Condition
Small cell lung cancer
Classification by specialty
| Pneumology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the relationship between CTCs and efficacy of treatment or prognosis
Basic objectives2
Others
Basic objectives -Others
To evaluate the relationship between CTCs and tumor markers
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Relationship between CTC counts and response rate or survival time
Key secondary outcomes
Relationship between CTC counts and tumor markers
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Histologically or cytologically proven small cell lung cancer
2. Chemotherapy and/or radiation are planned to initiate
3. Informed consent is obtained
Key exclusion criteria
none
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Tateaki Naito |
Organization
Shizuoka Cancer Center
Division name
Division of Thoracic Oncology
Zip code
Address
1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
TEL
+81-55-989-5222
t.naito@scchr.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Tateaki Naito |
Organization
Shizuoka Cancer Center
Division name
Division of Thoracic Oncology
Zip code
Address
1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
TEL
+81-55-989-5222
Homepage URL
http://www.scchr.jp/
t.naito@scchr.jp
Sponsor or person
Institute
Shizuoka Cancer Center
Institute
Department
Personal name
Funding Source
Organization
Shizuoka Cancer Center
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Department of thoracic surgery, Hyogo Collage of Medicine
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
静岡県立静岡がんセンター（静岡県）、兵庫医科大学（兵庫県）
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 03 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 03 | Month | 13 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Prognostic impact of circulating tumor cells in patients with small cell lung
cancer. J Thorac Oncol. 2012 Mar;7(3):512-9.
Naito T, Tanaka F, Ono A, Yoneda K, Takahashi T, Murakami H, Nakamura Y, Tsuya A, Kenmotsu H, Shukuya T, Kaira K, Koh Y, Endo M, Hasegawa S, Yamamoto N.
Management information
Registered date
| 2010 | Year | 03 | Month | 13 | Day |
Last modified on
| 2014 | Year | 02 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004043
